Áß³²¹ÌÀÇ ³ú½ÉºÎ ÀÚ±Ø Ä¡·á ½ÃÀå ¿¹Ãø(-2030³â) : Áö¿ªº° ºÐ¼® - Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°
South & Central America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User
»óǰÄÚµå : 1452614
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2024³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 79 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,450 £Ü 4,937,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 4,450 £Ü 6,368,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,450 £Ü 7,800,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Áß³²¹ÌÀÇ ³ú½ÉºÎ ÀÚ±Ø Ä¡·á ½ÃÀåÀº 2022³â 2,753¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 5,095¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. 2022-2030³âÀÇ CAGRÀº 8.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î Áß³²¹Ì ³ú½ÉºÎÀڱؿä¹ý ½ÃÀå ¼ºÀå °ßÀÎ

³ú½ÉºÎÀڱؼúÀº ±Ù±äÀåÀÌ»óÁõ, ÆÄŲ½¼º´, º»Å¼º ¶³¸² µî ¿îµ¿Àå¾Ö Ä¡·á¿¡ »ç¿ëµÇ´Â ÃÖ¼Òħ½ÀÀû Ç¥Àû¼ö¼úÀÔ´Ï´Ù. ÃÖ¼Òħ½À¼ö¼ú(MIS)Àº ±âÁ¸ ¼ö¼ú ¹æ¹ý¿¡ ºñÇØ ¸î °¡Áö ÀåÁ¡ÀÌ Àִµ¥, ½Åü¿¡ ´ëÇÑ ¿Ü»óÀ» ÃÖ¼ÒÈ­ÇÏ°í ¼ö¼ú ÈÄ ÅëÁõÀ» ÁÙÀ̰í ȸº¹ ¼Óµµ¸¦ ³ôÀ̸ç Ä¡·á °á°ú¸¦ Çâ»ó½Ãŵ´Ï´Ù. ·Îº¿ ¼ö¼úÀº ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ ÃֽŠÁøÈ­·Î, ±âÁ¸ÀÇ º¹°­°æ ¼ö¼ú¿¡ »ç¿ëµÇ¾ú´ø °Í°ú µ¿ÀÏÇÑ ÀÛÀº Àý°³Ã¢À» »ç¿ëÇÏ´Â Á¤¹Ð Àåºñ¸¦ ¿Ü°ú Àǻ翡°Ô Á¦°øÇϸç, MIS´Â °³º¹ ¼ö¼ú¿¡ ºñÇØ ÃâÇ÷ÀÌ Àû°í, ÁøÅëÁ¦ »ç¿ë·®ÀÌ ÀûÀ¸¸ç, ¼ö¼ú ÈÄ ÀÔ¿ø ±â°£ÀÌ Âª½À´Ï´Ù. ¶ÇÇÑ ÃÖ¼Òħ½À¼ö¼úÀº ±âÁ¸ ¼ö¼ú¹ýº¸´Ù ´õ ³ôÀº Á¤È®µµ¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ MISÀÇ ÀåÁ¡À¸·Î ÀÎÇØ ÀÔ¿ø ȯÀÚ°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ³ôÀº ¼ö¼ú ÀÌȯÀ²°ú »ç¸Á·ü¿¡ Á÷¸éÇÑ °í·É ȯÀڵ鿡°Ô ¼ö¼úÀ» ¹Þµµ·Ï À¯µµÇϰí ÀÖ½À´Ï´Ù. ÀÌó·³ ÃÖ¼Òħ½ÀÀû ¼ö¼úÀÇ ÀåÁ¡À¸·Î ÀÎÇÑ ¼ö¿ä Áõ°¡´Â Áß³²¹Ì ³ú½ÉºÎÀڱؼú ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Áß³²¹Ì ³ú½ÉºÎÀڱؿä¹ý ½ÃÀå °³¿ä

ºê¶óÁúÀº °í·ÉÈ­ Àα¸°¡ ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹ü¹Ìº¸°Ç±â±¸(PAHO)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é ºê¶óÁúÀÇ 60¼¼ ÀÌ»ó Àα¸´Â 3,000¸¸ ¸íÀ» ³Ñ¾î Àüü Àα¸ÀÇ 13%¸¦ Â÷ÁöÇϰí ÀÖÀ¸¸ç, 2030³â¿¡´Â ÀÌ ¿¬·ÉÃþÀÌ 5,000¸¸ ¸í¿¡ ´ÞÇϰí, ºê¶óÁú Àα¸ÀÇ 24%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºê¶óÁú Åë°èû¿¡ µû¸£¸é 2050³â±îÁö 65¼¼ ÀÌ»ó Àα¸´Â ºê¶óÁú Àüü Àα¸ÀÇ 36%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ½Å°æ ÁúȯÀÇ À¯º´·üÀº ºê¶óÁúÀÇ ³ëÀÎ Àα¸¿¡ ÀÇÁ¸Çϱ⠶§¹®¿¡ ÆÄŲ½¼ º´ ¹× ¾ËÃ÷ÇÏÀÌ¸Ó º´°ú °°Àº ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Ä¡·á¸¦ À§ÇÑ ³ú½ÉºÎÀڱؿä¹ý¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¶ÇÇÑ 2023³â¿¡ ¹ßÇ¥µÈ 'Trends in mortality from Alzheimer's disease in Brazil, 2000-2019'¿¡ µû¸£¸é ºê¶óÁúÀÇ °í·ÉÈ­ ¹× »ç¸Á·ü Áõ°¡¿Í ÇÔ²² ¾ËÃ÷ÇÏÀ̸Ӻ´ÀÌ °Ç°­»óÀÇ Å« ¹®Á¦·Î ´ëµÎµÇ°í ÀÖ´Ù°í ÇÕ´Ï´Ù. 2009-2019³â±îÁö ºê¶óÁú¿¡¼­ ¾ËÃ÷ÇÏÀ̸Ӻ´À¸·Î ÀÎÇÑ »ç¸ÁÀÌ 49% Áõ°¡ÇÏ¿© »ç¸Á ¿øÀÎ Áß 7À§¸¦ Â÷ÁöÇß½À´Ï´Ù. °°Àº ±â°£ ºê¶óÁúÀÇ »ç¸ÁÀÚ ¼ö´Â 21¸¸ 1,600¸í ÀÌ»óÀ̾ú½À´Ï´Ù. ¶ÇÇÑ »ç¸ÁÀÚÀÇ 73%´Â 80¼¼ ÀÌ»ó, 27%´Â 60-79¼¼¿´½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ÇâÈÄ ¼ö³â°£ ºê¶óÁú¿¡¼­ Áúº´ Ä¡·á¸¦ À§ÇÑ ³ú½ÉºÎÀÚ±Ø Ä¡·á Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áß³²¹Ì ³ú½ÉºÎÀڱؿä¹ý ½ÃÀå ¸ÅÃâ ¹× 2030³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)

Áß³²¹Ì ³ú½ÉºÎÀڱؿä¹ý ½ÃÀå ¼¼ºÐÈ­

Áß³²¹Ì ³ú½ÉºÎÀڱؿä¹ý ½ÃÀåÀº Á¦Ç°, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, ±¹°¡º°·Î ºÐ·ùµË´Ï´Ù.

Á¦Ç°º°·Î Áß³²¹Ì ³ú½ÉºÎÀÚ±ØÄ¡·á ½ÃÀåÀº ´ÜÀÏ Ã¤³Î ³ú½ÉºÎÀڱرâ, µà¾ó ä³Î ³ú½ÉºÎÀڱرâ, ¼ÒÇÁÆ®¿þ¾î ¹× ¾×¼¼¼­¸®·Î ±¸ºÐµÇ¸ç, 2022³â¿¡´Â µà¾ó ä³Î ³ú½ÉºÎÀڱر⠺ι®ÀÌ Áß³²¹Ì ³ú½ÉºÎÀÚ±ØÄ¡·á ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ëµµº°·Î Áß³²¹Ì ³ú½ÉºÎÀڱؿä¹ý ½ÃÀåÀº ÆÄŲ½¼º´, ¶³¸², ±Ù±äÀåÀÌ»óÁõ, °£Áú, ¾ËÃ÷ÇÏÀ̸Ӻ´, ±âŸ·Î ±¸ºÐµÇ¸ç, 2022³â¿¡´Â ÆÄŲ½¼º´ ºÎ¹®ÀÌ Áß³²¹Ì ³ú½ÉºÎÀڱؿä¹ý ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î Áß³²¹Ì ³ú½ÉºÎÀÚ±ØÄ¡·á ½ÃÀåÀº º´¿ø, ½Å°æ°ú Ŭ¸®´Ð, ¿Ü·¡ ¼ö¼ú¼¾ÅÍ, ±âŸ·Î ±¸ºÐµÇ¸ç, 2022³â¿¡´Â º´¿ø ºÎ¹®ÀÌ ³²¹Ì ³ú½ÉºÎÀÚ±ØÄ¡·á ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±¹°¡º°·Î Áß³²¹Ì ³ú½ÉºÎÀÚ±ØÄ¡·á ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ ³²¹Ì·Î ±¸ºÐµÇ¸ç, 2022³â¿¡´Â ºê¶óÁúÀÌ Áß³²¹Ì ³ú½ÉºÎÀÚ±ØÄ¡·á ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Abbott, Medtronic, Boston Sci, Leva Nova´Â Áß³²¹Ì ³ú½ÉºÎÀÚ±ØÄ¡·á ½ÃÀå¿¡¼­ »ç¾÷À» ¿î¿µÇϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå Áß³²¹ÌÀÇ ³ú½ÉºÎ ÀÚ±Ø Ä¡·á ½ÃÀå ±¸µµ

Á¦5Àå ³²¹Ì¿Í Á߾ӾƸ޸®Ä«ÀÇ ³ú½ÉºÎ ÀÚ±Ø ½ÃÀå : ÁÖ¿ä »ê¾÷ ¿ªÇÐ

Á¦6Àå ³ú½ÉºÎ ÀÚ±Ø ½ÃÀå : Áß³²¹Ì ½ÃÀå ºÐ¼®

Á¦7Àå Áß³²¹ÌÀÇ ³ú½ÉºÎ ÀÚ±Ø Ä¡·á ½ÃÀå - 2030³â±îÁöÀÇ ¸ÅÃâ°ú ¿¹Ãø : Á¦Ç°º°

Á¦8Àå Áß³²¹ÌÀÇ ³ú½ÉºÎ ÀÚ±Ø Ä¡·á ½ÃÀå : ¸ÅÃâ°ú 2030³â±îÁöÀÇ ¿¹Ãø : ¿ëµµº°

Á¦9Àå Áß³²¹ÌÀÇ ³ú½ÉºÎ ÀÚ±Ø Ä¡·á ½ÃÀå : ¸ÅÃâ°ú 2030³â±îÁöÀÇ ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå Áß³²¹ÌÀÇ ³ú½ÉºÎ ÀÚ±Ø Ä¡·á ½ÃÀå : ±¹°¡º° ºÐ¼®

Á¦11Àå Áß³²¹ÌÀÇ ³ú½ÉºÎ ÀÚ±Ø Ä¡·á ½ÃÀå ¾÷°è »óȲ

Á¦12Àå Áß³²¹ÌÀÇ ³ú½ÉºÎ ÀÚ±Ø Ä¡·á ½ÃÀå : ÁÖ¿ä ±â¾÷ °³¿ä

Á¦13Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The South & Central America deep brain simulation market is expected to grow from US$ 27.53 million in 2022 to US$ 50.95 million by 2030. It is estimated to grow at a CAGR of 8.0% from 2022 to 2030.

Increasing Demand for Minimally Invasive Surgery Drive South & Central America Deep Brain Simulation Market

Deep brain stimulation is a minimally invasive targeted surgery used to treat movement disorders in dystonia, Parkinson's disease, and essential tremor. Minimally invasive surgeries (MIS) offer several advantages over traditional surgical techniques. MIS minimizes trauma to the body, reduces postoperative pain, increases recovery speed, and improves outcomes. Robotic procedures represent the latest evolution in minimally invasive procedures, providing surgeons with precision equipment that uses the same small incisions used in traditional laparoscopy. MIS leads to less blood loss, less analgesic use, and shorter postoperative hospital stay than open surgery. In addition, minimally invasive surgery indicates a higher accuracy rate than traditional surgical methods. Also, these procedures require tiny incisions large enough to insert thin tubes and cameras. These benefits of MIS are increasing inpatients and have encouraged older patients who face high operative morbidity and mortality to seek surgery. Thus, the rising demand for minimally invasive surgeries due to their advantages bolsters the South & Central America deep brain stimulation (DBS) market growth.

South & Central America Deep Brain Simulation Market Overview

In Brazil, the aging population is rapidly growing. According to the data from Pan American Health Organization (PAHO), Brazil has over 30 million people aged 60 years and older, representing 13% of the country's population. By 2030, this age group is expected to reach ~50 million, representing 24% of the Brazilian population. As per the Brazil Statistical Institute, the country's population aged 65 and above is expected to hold 36% share of the total population of Brazil by 2050. Further, the prevalence of neurological disorders is dependent on the geriatric population in Brazil; thus, the increasing incidences of neurological diseases, such as Parkinson's disease and Alzheimer's disease, are likely to propel the demand for deep brain stimulation (DBS) for treatment. Moreover, as per the study, "Trends in mortality from Alzheimer's disease in Brazil, 2000-2019," published in 2023, in Brazil, Alzheimer's disease has become a major health concern since the population is increasingly aging, coupled with the increasing mortality rates and the growing prevalence of the disease in the country. During 2009-2019, there was a 49% increase in deaths due to Alzheimer's disease in the country, making it the seventh leading cause of death. More than 211,600 deaths were due to the disease in the same period in Brazil. Furthermore, 73% of the deaths were of people aged 80 and above, and 27% were in the 60-79 age group. Thus, the above-mentioned factors are expected to increase the demand for DBS devices for the treatment of diseases in the country in the coming years.

South & Central America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Deep Brain Simulation Market Segmentation

The South & Central America deep brain simulation market is segmented into product, application, end user, and country.

Based on product, the South & Central America deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the South & Central America deep brain simulation market.

Based on application, the South & Central America deep brain simulation market is segmented into Parkinson's disease, tremor, dystonia, epilepsy, Alzheimer's disease, and others. In 2022, the Parkinson's disease segment registered the largest share in the South & Central America deep brain simulation market.

Based on end user, the South & Central America deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the South & Central America deep brain simulation market.

Based on country, the South & Central America deep brain simulation market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2022, Brazil registered the largest share in the South & Central America deep brain simulation market.

Abbott, Medtronic, Boston Sci, and Leva Nova are some of the leading companies operating in the South & Central America deep brain simulation market.

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. South & Central America Deep Brain Simulation Market Landscape

5. South & Central America Deep Brain Simulation Market - Key Industry Dynamics

6. Deep Brain Simulation Market - South & Central America Market Analysis

7. South & Central America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Product

8. South & Central America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Application

9. South & Central America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by End User

10. South & Central America Deep Brain Simulation Market - Country Analysis

11. South & Central America Deep Brain Simulation Market Industry Landscape

12. South & Central America Deep Brain Simulation Market, Key Company Profiles

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â